Nectar Lifesciences Limited — JV/Acquisition, 02-03-2026: Acquisition

Nectar Lifesciences is strategically diversifying its business by acquiring 100% of Avensis Exports Private Limited (AEPL) for ₹0.25 Cr. This move marks Nectar's entry into the real estate sector. AEPL, despite having no recent turnover, offers land exposures and existing collaborations, which will help Nectar Lifesciences establish a footprint and strengthen its position in real estate. This acquisition is set to unlock new growth avenues and broaden the company's overall business portfolio.